Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial
Titel:
Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial
Auteur:
Tan, Antoinette R Wright, Gail S Thummala, Anu R Danso, Michael A Popovic, Lazar Pluard, Timothy J Han, Hyo S Vojnović, Željko Vasev, Nikola Ma, Ling Richards, Donald A Wilks, Sharon T Milenković, Dušan Yang, Zhao Antal, Joyce M Morris, Shannon R O'Shaughnessy, Joyce